APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Manufacturing and Contract

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Selected research

Industry Research

Pharmaceutical Contract Manufacturing and Contract Industry Research Report 2026

30 December 2025137 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Manufacturing and Contract Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Manufacturing and Contract Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Manufacturing and Contract Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Manufacturing and Contract Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Manufacturing and Contract Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

Report Scope

Read the full market overview

This report quantifies the global Pharmaceutical Contract Manufacturing and Contract market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Contract Manufacturing and Contract.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical Contract Manufacturing and Contract Market by Company

Catalent

Thermo Fisher Scientific

Lonza

Boehringer Ingelheim

Fareva

Recipharm

Aenova

AbbVie

Baxter

Nipro Corp

Sopharma

Famar

Vetter

Shandong Xinhua

Piramal

Mylan

Dr. Reddy’s

Zhejiang Hisun

Zhejiang Huahai

Jubilant

Pharmaceutical Contract Manufacturing and Contract Segment by Type

Oral

Injectable

API

Other

Pharmaceutical Contract Manufacturing and Contract Segment by Application

Small Medium Enterprise

Large Enterprise

Pharmaceutical Contract Manufacturing and Contract Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Manufacturing and Contract market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Manufacturing and Contract and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Manufacturing and Contract.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2021-2026) Table 7. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2027-2032) Table 9. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2021-2026) Table 11. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2027-2032) Table 13. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2027-2032) Table 18. Pharmaceutical Contract Manufacturing and Contract Industry Trends Table 19. Pharmaceutical Contract Manufacturing and Contract Industry Drivers Table 20. Pharmaceutical Contract Manufacturing and Contract Industry Opportunities and Challenges Table 21. Pharmaceutical Contract Manufacturing and Contract Market Restraints Table 22. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2021-2026) Table 24. Global Pharmaceutical Contract Manufacturing and Contract Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Headquarters and Area Served Table 26. Global Pharmaceutical Contract Manufacturing and Contract Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmaceutical Contract Manufacturing and Contract by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032) & (US$ Million) Table 45. Catalent Company Information Table 46. Catalent Business Overview Table 47. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 48. Catalent Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 49. Catalent Recent Developments Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 53. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 54. Thermo Fisher Scientific Recent Developments Table 55. Lonza Company Information Table 56. Lonza Business Overview Table 57. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 58. Lonza Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 59. Lonza Recent Developments Table 60. Boehringer Ingelheim Company Information Table 61. Boehringer Ingelheim Business Overview Table 62. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 63. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 64. Boehringer Ingelheim Recent Developments Table 65. Fareva Company Information Table 66. Fareva Business Overview Table 67. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 68. Fareva Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 69. Fareva Recent Developments Table 70. Recipharm Company Information Table 71. Recipharm Business Overview Table 72. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 73. Recipharm Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 74. Recipharm Recent Developments Table 75. Aenova Company Information Table 76. Aenova Business Overview Table 77. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 78. Aenova Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 79. Aenova Recent Developments Table 80. AbbVie Company Information Table 81. AbbVie Business Overview Table 82. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 83. AbbVie Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 84. AbbVie Recent Developments Table 85. Baxter Company Information Table 86. Baxter Business Overview Table 87. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 88. Baxter Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 89. Baxter Recent Developments Table 90. Nipro Corp Company Information Table 91. Nipro Corp Business Overview Table 92. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 93. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 94. Nipro Corp Recent Developments Table 95. Sopharma Company Information Table 96. Sopharma Business Overview Table 97. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 98. Sopharma Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 99. Sopharma Recent Developments Table 100. Famar Company Information Table 101. Famar Business Overview Table 102. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 103. Famar Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 104. Famar Recent Developments Table 105. Vetter Company Information Table 106. Vetter Business Overview Table 107. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 108. Vetter Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 109. Vetter Recent Developments Table 110. Shandong Xinhua Company Information Table 111. Shandong Xinhua Business Overview Table 112. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 113. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 114. Shandong Xinhua Recent Developments Table 115. Piramal Company Information Table 116. Piramal Business Overview Table 117. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 118. Piramal Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 119. Piramal Recent Developments Table 120. Mylan Company Information Table 121. Mylan Business Overview Table 122. Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 123. Mylan Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 124. Mylan Recent Developments Table 125. Dr. Reddy’s Company Information Table 126. Dr. Reddy’s Business Overview Table 127. Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 128. Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 129. Dr. Reddy’s Recent Developments Table 130. Zhejiang Hisun Company Information Table 131. Zhejiang Hisun Business Overview Table 132. Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 133. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 134. Zhejiang Hisun Recent Developments Table 135. Zhejiang Huahai Company Information Table 136. Zhejiang Huahai Business Overview Table 137. Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 138. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 139. Zhejiang Huahai Recent Developments Table 140. Jubilant Company Information Table 141. Jubilant Business Overview Table 142. Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) & (US$ Million) Table 143. Jubilant Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 144. Jubilant Recent Developments Table 145. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical Contract Manufacturing and Contract Product Image Figure 5. Global Pharmaceutical Contract Manufacturing and Contract Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Type: 2025 VS 2032 Figure 7. Oral Product Figure 8. Injectable Product Figure 9. API Product Figure 10. Other Product Figure 11. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2025 VS 2032 Figure 13. Small Medium Enterprise Product Figure 14. Large Enterprise Product Figure 15. Global Pharmaceutical Contract Manufacturing and Contract Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Pharmaceutical Contract Manufacturing and Contract Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region: 2025 VS 2032 Figure 18. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players in 2025 Figure 19. Global Pharmaceutical Contract Manufacturing and Contract Manufacturers Established Date Figure 20. Global Top 5 and 10 Pharmaceutical Contract Manufacturing and Contract Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021-2032) Figure 24. United States Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021-2032) Figure 27. Europe Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021-2032) Figure 29. Germany Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021-2032) Figure 39. China Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021-2032) Figure 44. Australia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2021-2032) Figure 49. Brazil Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Catalent Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 56. Lonza Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 57. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 58. Fareva Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 59. Recipharm Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 60. Aenova Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 61. AbbVie Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 62. Baxter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 63. Nipro Corp Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 64. Sopharma Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 65. Famar Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 66. Vetter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 67. Shandong Xinhua Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 68. Piramal Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 69. Mylan Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 70. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 71. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 72. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026) Figure 73. Jubilant Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)

Scope & coverage.

Types
  • Oral
  • Injectable
  • API
  • Other
Applications
  • Small Medium Enterprise
  • Large Enterprise
Companies covered
  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • Boehringer Ingelheim
  • Fareva
  • Recipharm
  • Aenova
  • AbbVie
  • Baxter
  • Nipro Corp
  • Sopharma
  • Famar
  • Vetter
  • Shandong Xinhua
  • Piramal
  • Mylan
  • Dr. Reddy’s
  • Zhejiang Hisun
  • Zhejiang Huahai
  • Jubilant

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharmaceutical Contract Manufacturing and Contract by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Oral
  5. 2.2.3 Injectable
  6. 2.2.4 API
  7. 2.2.5 Other
  8. 2.3 Pharmaceutical Contract Manufacturing and Contract by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Small Medium Enterprise
  11. 2.3.3 Large Enterprise
  12. 2.4 Assumptions and Limitations
3 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Type
  1. 3.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2021-2026)
  2. 3.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application
  1. 4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Application (2021-2026)
  2. 4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Pharmaceutical Contract Manufacturing and Contract Market Perspective (2021-2032)
  2. 5.2 Global Pharmaceutical Contract Manufacturing and Contract Growth Trends by Region
  3. 5.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Region (2021-2026)
  5. 5.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2027-2032)
  6. 5.3 Pharmaceutical Contract Manufacturing and Contract Market Dynamics
  7. 5.3.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
  8. 5.3.2 Pharmaceutical Contract Manufacturing and Contract Market Drivers
  9. 5.3.3 Pharmaceutical Contract Manufacturing and Contract Market Challenges
  10. 5.3.4 Pharmaceutical Contract Manufacturing and Contract Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue
  2. 6.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2021-2026)
  3. 6.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Pharmaceutical Contract Manufacturing and Contract Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Pharmaceutical Contract Manufacturing and Contract Head Office and Area Served
  6. 6.4 Global Pharmaceutical Contract Manufacturing and Contract Players, Product Type & Application
  7. 6.5 Global Pharmaceutical Contract Manufacturing and Contract Manufacturers Established Date
  8. 6.6 Global Pharmaceutical Contract Manufacturing and Contract Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
  4. 7.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
  4. 8.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
  2. 9.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
  2. 10.2 South America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
  4. 10.4 South America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
  2. 11.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Catalent
  2. 12.1.1 Catalent Company Information
  3. 12.1.2 Catalent Business Overview
  4. 12.1.3 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  5. 12.1.4 Catalent Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  6. 12.1.5 Catalent Recent Developments
  7. 12.2 Thermo Fisher Scientific
  8. 12.2.1 Thermo Fisher Scientific Company Information
  9. 12.2.2 Thermo Fisher Scientific Business Overview
  10. 12.2.3 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  11. 12.2.4 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  12. 12.2.5 Thermo Fisher Scientific Recent Developments
  13. 12.3 Lonza
  14. 12.3.1 Lonza Company Information
  15. 12.3.2 Lonza Business Overview
  16. 12.3.3 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  17. 12.3.4 Lonza Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  18. 12.3.5 Lonza Recent Developments
  19. 12.4 Boehringer Ingelheim
  20. 12.4.1 Boehringer Ingelheim Company Information
  21. 12.4.2 Boehringer Ingelheim Business Overview
  22. 12.4.3 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  23. 12.4.4 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  24. 12.4.5 Boehringer Ingelheim Recent Developments
  25. 12.5 Fareva
  26. 12.5.1 Fareva Company Information
  27. 12.5.2 Fareva Business Overview
  28. 12.5.3 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  29. 12.5.4 Fareva Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  30. 12.5.5 Fareva Recent Developments
  31. 12.6 Recipharm
  32. 12.6.1 Recipharm Company Information
  33. 12.6.2 Recipharm Business Overview
  34. 12.6.3 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  35. 12.6.4 Recipharm Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  36. 12.6.5 Recipharm Recent Developments
  37. 12.7 Aenova
  38. 12.7.1 Aenova Company Information
  39. 12.7.2 Aenova Business Overview
  40. 12.7.3 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  41. 12.7.4 Aenova Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  42. 12.7.5 Aenova Recent Developments
  43. 12.8 AbbVie
  44. 12.8.1 AbbVie Company Information
  45. 12.8.2 AbbVie Business Overview
  46. 12.8.3 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  47. 12.8.4 AbbVie Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  48. 12.8.5 AbbVie Recent Developments
  49. 12.9 Baxter
  50. 12.9.1 Baxter Company Information
  51. 12.9.2 Baxter Business Overview
  52. 12.9.3 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  53. 12.9.4 Baxter Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  54. 12.9.5 Baxter Recent Developments
  55. 12.10 Nipro Corp
  56. 12.10.1 Nipro Corp Company Information
  57. 12.10.2 Nipro Corp Business Overview
  58. 12.10.3 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  59. 12.10.4 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  60. 12.10.5 Nipro Corp Recent Developments
  61. 12.11 Sopharma
  62. 12.11.1 Sopharma Company Information
  63. 12.11.2 Sopharma Business Overview
  64. 12.11.3 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  65. 12.11.4 Sopharma Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  66. 12.11.5 Sopharma Recent Developments
  67. 12.12 Famar
  68. 12.12.1 Famar Company Information
  69. 12.12.2 Famar Business Overview
  70. 12.12.3 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  71. 12.12.4 Famar Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  72. 12.12.5 Famar Recent Developments
  73. 12.13 Vetter
  74. 12.13.1 Vetter Company Information
  75. 12.13.2 Vetter Business Overview
  76. 12.13.3 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  77. 12.13.4 Vetter Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  78. 12.13.5 Vetter Recent Developments
  79. 12.14 Shandong Xinhua
  80. 12.14.1 Shandong Xinhua Company Information
  81. 12.14.2 Shandong Xinhua Business Overview
  82. 12.14.3 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  83. 12.14.4 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  84. 12.14.5 Shandong Xinhua Recent Developments
  85. 12.15 Piramal
  86. 12.15.1 Piramal Company Information
  87. 12.15.2 Piramal Business Overview
  88. 12.15.3 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  89. 12.15.4 Piramal Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  90. 12.15.5 Piramal Recent Developments
  91. 12.16 Mylan
  92. 12.16.1 Mylan Company Information
  93. 12.16.2 Mylan Business Overview
  94. 12.16.3 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  95. 12.16.4 Mylan Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  96. 12.16.5 Mylan Recent Developments
  97. 12.17 Dr. Reddy’s
  98. 12.17.1 Dr. Reddy’s Company Information
  99. 12.17.2 Dr. Reddy’s Business Overview
  100. 12.17.3 Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  101. 12.17.4 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  102. 12.17.5 Dr. Reddy’s Recent Developments
  103. 12.18 Zhejiang Hisun
  104. 12.18.1 Zhejiang Hisun Company Information
  105. 12.18.2 Zhejiang Hisun Business Overview
  106. 12.18.3 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  107. 12.18.4 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  108. 12.18.5 Zhejiang Hisun Recent Developments
  109. 12.19 Zhejiang Huahai
  110. 12.19.1 Zhejiang Huahai Company Information
  111. 12.19.2 Zhejiang Huahai Business Overview
  112. 12.19.3 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  113. 12.19.4 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  114. 12.19.5 Zhejiang Huahai Recent Developments
  115. 12.20 Jubilant
  116. 12.20.1 Jubilant Company Information
  117. 12.20.2 Jubilant Business Overview
  118. 12.20.3 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2021-2026)
  119. 12.20.4 Jubilant Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  120. 12.20.5 Jubilant Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst